...
首页> 外文期刊>BMC Health Services Research >The impact of decision aids to enhance shared decision making for diabetes (the DAD study): protocol of a cluster randomized trial
【24h】

The impact of decision aids to enhance shared decision making for diabetes (the DAD study): protocol of a cluster randomized trial

机译:决策辅助的影响可增强糖尿病的共同决策制定能力(DAD研究):一项随机分组试验的方案

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Shared decision making contributes to high quality healthcare by promoting a patient-centered approach. Patient involvement in selecting the components of a diabetes medication program that best match the patient’s values and preferences may also enhance medication adherence and improve outcomes. Decision aids are tools designed to involve patients in shared decision making, but their adoption in practice has been limited. In this study, we propose to obtain a preliminary estimate of the impact of patient decision aids vs. usual care on measures of patient involvement in decision making, diabetes care processes, medication adherence, glycemic and cardiovascular risk factor control, and resource utilization. In addition, we propose to identify, describe, and explain factors that promote or inhibit the routine embedding of decision aids in practice. Methods/Design We will be conducting a mixed-methods study comprised of a cluster-randomized, practical, multicentered trial enrolling clinicians and their patients (n?=?240) with type 2 diabetes from rural and suburban primary care practices (n?=?8), with an embedded qualitative study to examine factors that influence the incorporation of decision aids into routine practice. The intervention will consist of the use of a decision aid (Statin Choice and Aspirin Choice, or Diabetes Medication Choice) during the clinical encounter. The qualitative study will include analysis of video recordings of clinical encounters and in-depth, semi-structured interviews with participating patients, clinicians, and clinic support staff, in both trial arms. Discussion Upon completion of this trial, we will have new knowledge about the effectiveness of diabetes decision aids in these practices. We will also better understand the factors that promote or inhibit the successful implementation and normalization of medication choice decision aids in the care of chronic patients in primary care practices. Trial registration NCT00388050
机译:背景技术共同的决策制定通过促进以患者为中心的方法,为高质量医疗保健做出了贡献。患者参与选择最适合患者价值观和偏好的糖尿病药物治疗计划的组成部分,也可能会增强药物依从性并改善治疗效果。决策辅助工具是旨在使患者参与共同决策的工具,但是在实践中他们的采用受到限制。在这项研究中,我们建议对患者决策辅助与常规护理对患者参与决策,糖尿病护理过程,用药依从性,血糖和心血管危险因素控制以及资源利用等方面的影响进行初步估计。另外,我们建议识别,描述和解释在实践中促进或抑制常规决策辅助程序嵌入的因素。方法/设计我们将进行一项混合方法研究,该研究由来自农村和郊区初级保健实践(n ==)的2类糖尿病的临床医师及其患者(n = 240)组成,采用集群随机,实用,多中心试验纳入。 8),进行了嵌入式定性研究,以研究影响将决策辅助工具纳入常规实践的因素。干预将包括在临床过程中使用决策辅助工具(他汀类药物选择和阿司匹林选择或糖尿病药物选择)。定性研究将包括对两个临床试验中的患者,临床医生和临床支持人员的临床遭遇的视频记录进行分析,并进行深度,半结构化的访谈。讨论该试验完成后,我们将获得有关糖尿病决策辅助剂在这些实践中的有效性的新知识。我们还将更好地了解在基层医疗实践中促进或抑制成功实施药物选择决策并使药物选择决策辅助正常化的因素。试用注册NCT00388050

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号